Medication

House Speaker Nancy Pelosi of Calif., gestures while speakings during a news conference on Capitol Hill in Washington, Thursday, Oct. 17, 2019. (AP Photo/Pablo Martinez Monsivais)
October 17, 2019 - 8:10 pm
WASHINGTON (AP) — House Speaker Nancy Pelosi is plowing ahead with her bill to allow Medicare to negotiate prescription drug prices despite a breakdown in relations with her chief bargaining partner on the issue — President Donald Trump. The nonpartisan Congressional Budget Office has estimated the...
Read More
House Speaker Nancy Pelosi of Calif., gestures while speakings during a news conference on Capitol Hill in Washington, Thursday, Oct. 17, 2019. (AP Photo/Pablo Martinez Monsivais)
October 17, 2019 - 4:13 pm
WASHINGTON (AP) — House Speaker Nancy Pelosi is plowing ahead with her bill allowing Medicare to negotiate prescription drug prices despite a breakdown in relations with her chief bargaining partner on the issue — President Donald Trump. The nonpartisan Congressional Budget Office has estimated the...
Read More
FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results Tuesday, Oct. 14, 2019. (AP Photo/Gene J. Puskar, File)
October 15, 2019 - 8:37 am
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson's third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world's biggest maker of health care products also...
Read More
FILE - In this Sept. 25, 2019, file photo, the West Front of the U.S. Capitol in Washington. Impeachment may have leapfrogged to the top of the national agenda, but members of Congress still have their day jobs as legislators _ and they’re returning to work this coming week with mixed hopes of success. (AP Photo/J. Scott Applewhite, File)
October 13, 2019 - 10:47 am
WASHINGTON (AP) — Impeachment may have leapfrogged to the top of the national agenda, but members of Congress still have their day jobs as legislators, and they're returning to Washington this coming week with mixed hopes of success. It's a volatile, difficult-to-predict time in Washington as...
Read More
FILE - In this Sept. 25, 2019, file photo, the West Front of the U.S. Capitol in Washington. Impeachment may have leapfrogged to the top of the national agenda, but members of Congress still have their day jobs as legislators _ and they’re returning to work this coming week with mixed hopes of success. (AP Photo/J. Scott Applewhite, File)
October 13, 2019 - 8:22 am
WASHINGTON (AP) — Impeachment may have leapfrogged to the top of the national agenda, but members of Congress still have their day jobs as legislators, and they're returning to work this week with mixed hopes of success. It's a difficult-to-predict time when it comes to possible deals between...
Read More
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 11, 2019 - 8:02 pm
WHITE PLAINS, N.Y. (AP) — A judge is pushing for a settlement of more than 2,600 lawsuits facing OxyContin maker Purdue Pharma with a decision Friday to pause litigation against the company and members of the wealthy Sackler family that owns the company. In a hearing Friday, U.S. Bankruptcy Judge...
Read More
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 11, 2019 - 2:20 pm
A judge will halt lawsuits against Purdue Pharma and its owners for six months in hopes of finalizing a settlement over the OxyContin maker's role in the national opioid crisis, he said Friday. In a hearing, U.S. Bankruptcy Judge Robert Drain strongly brushed aside the argument from a group of...
Read More
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials are again warning doctors against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors Thursday, Oct. 10, 2019, to share such decisions with patients. (AP Photo/Mark Lennihan, File)
October 10, 2019 - 12:19 pm
U.S. health officials again warned doctors Thursday against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors to share such decisions with patients. The agency published steps for doctors in a six...
Read More
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials are again warning doctors against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors Thursday, Oct. 10, 2019, to share such decisions with patients. (AP Photo/Mark Lennihan, File)
October 10, 2019 - 11:03 am
U.S. health officials are again warning doctors against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors to share such decisions with patients. The agency Thursday published steps for doctors in...
Read More
FILE - In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. A Philadelphia jury has ruled that Johnson & Johnson and Janssen Pharmaceuticals must pay $8 billion in punitive damages over an antipsychotic drug linked to the abnormal growth of female breast tissue in boys. A law firm for the plaintiff released a statement Tuesday, Oct. 8, 2019, saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal. (AP Photo/Mel Evans, File)
October 08, 2019 - 8:27 pm
PHILADELPHIA (AP) — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys. Johnson and Johnson...
Read More

Pages